CB vs ROIV · P/E 14, rev $59.40B vs rev $29.1M
Chubb Ltd (CB) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported ROIV revenue for 2025-03-31 was $29.1M. Net income was -$356.7M. Revenue was down 11.2% from 2024-03-31 to 2025-03-31. ROIV currently screens at market cap $7.47B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the CB and ROIV stock pages for the full models.
Not investment advice.